AI platform

46 articles
Investing.comInvesting.com··Thomas Hughes

SoundHound AI Stock Signals Reversal With 50% Upside as Institutional Buyers Accumulate

SoundHound AI reports 52% YoY revenue growth to $44.2M with institutional accumulation accelerating. Strategic acquisitions and product launches signal potential inflection point.
SOUNSOUNWLPSNrevenue growthinstitutional buying
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Arcadia Acquires ENGIE Impact to Dominate Energy Management Market

Arcadia acquires ENGIE Impact to create major energy management platform serving 1,500+ enterprises, including 25% of Fortune 500, managing 4.5M meters globally.
RKDAacquisitionenterprise software
The Motley FoolThe Motley Fool··Jennifer Saibil

Palantir Stock Down 20% YTD but May 4 Earnings Could Spark Turnaround

Palantir stock down 20% this year despite strong growth. Q1 earnings on May 4 will test whether 226 P/E ratio is justified.
SNOWPLTRAIstock valuationrevenue growth
GlobeNewswire Inc.GlobeNewswire Inc.··Jonathan Covey

Anuma Launches Privacy-First AI Platform With Unified Model Access and Encrypted Memory

Anuma debuts public AI platform offering encrypted, user-owned memory across ChatGPT, Claude, Gemini, and other leading models via single subscription starting at $9.99/month.
BATRBAI platformsubscription service
BenzingaBenzinga··Globe Newswire

Auddia Raises $12M in Public Offering to Fuel Growth Initiatives

Auddia raises $12M in public offering, selling 5.08M shares at $2.36 per share. Capital designated for working capital and corporate initiatives.
AUUDwarrantspublic offering
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

RYVYL and Roundtable Launch AI-Powered DeFi Platform to Disrupt Media Tech Stack

RYVYL Inc. ($RVYL) and RTB Digital unveiled an AI-DeFi-Web3 platform targeting $1B+ media cost savings by consolidating 17-vendor technology stacks.
RVYLWeb3AI platform
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

ODDITY Tech Hit With Securities Lawsuit Over Undisclosed Ad Algorithm Changes

Class action lawsuit filed against $ODD for allegedly concealing advertising partner algorithm changes that drove up customer acquisition costs, triggering 49% stock plunge.
ODDsecurities fraudclass action lawsuit
The Motley FoolThe Motley Fool··Rick Orford

SoundHound AI Lands Major Telecom Deal, But Path to Profitability Remains Unclear

SoundHound AI secured a telecom partnership to scale its AI platform, though persistent losses and valuation concerns cloud the investment outlook.
SOUNSOUNWexecution riskstock valuation
BenzingaBenzinga··Globe Newswire

Auddia Taps Capital Markets with $12M Offering Ahead of 2026 Close

Auddia priced $12M public offering at $2.36/share, consisting of 5.1M shares and warrants, closing April 2026.
AUUDwarrantspublic offering
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

ODDITY Tech Stock Crashes 49% as Ad Partner Algorithm Shift Triggers Revenue Collapse

ODDITY Tech ($ODD) crashed 49% after disclosing 30% Q1 revenue decline from advertising partner algorithm changes. Securities lawsuit filed alleging misstatements about platform strength.
ODDsecurities class actionmisleading statements
The Motley FoolThe Motley Fool··Keithen Drury

Palantir's 30% Plunge Still Leaves Stock Trading at Dizzying Valuations

Palantir stock has fallen 30% from peaks but remains overvalued at 231x earnings despite 74% revenue growth and record margins, analysts say.
PLTRvaluationrevenue growth
GlobeNewswire Inc.GlobeNewswire Inc.··Aptean

Aptean Launches AI Platform for Business Central On-Premises, Avoiding Cloud Migration

Aptean launches AppCentral, an AI platform with 10 pre-built agents for on-premises Business Central users, enabling AI deployment without cloud migration.
MSFTautomationAI agents
BenzingaBenzinga··Lekha Gupta

Arrive AI Shares Tumble Despite Earnings Beat and Board Expansion

$ARAI falls 2.85% to 98 cents despite beating Q4 EPS expectations and appointing T-Mobile executive to board.
ARAIearnings beattechnology sector
The Motley FoolThe Motley Fool··Emma Newbery

Tech Stocks Surge as Market Shrugs Off Oil Disruptions

U.S. stocks rose April 13 as tech led gains: S&P 500 +1.02%, Nasdaq +1.23%, Dow +0.63%. Oracle surged 12.74% on AI announcement despite oil disruptions weighing on sentiment.
DELLGSGSpAGSpCGSpD+3stock marketsoftware stocks
The Motley FoolThe Motley Fool··David Jagielski, Cpa

Palantir's Stellar Growth Masks a Troubling Valuation Problem

Palantir's 70% growth and Rule of 40 score of 127% mask a critical weakness: diluted EPS of $0.63 yields a 200x earnings multiple, raising serious valuation concerns.
PLTRvaluationrevenue growth
The Motley FoolThe Motley Fool··Micah Zimmerman

Palantir's AI Pivot Triggers Analyst Reversal: Why $PLTR Deserves Its Premium Valuation

Analyst reverses bearish stance on $PLTR citing AI boot camp model driving 109% U.S. commercial growth and 115%+ guidance, justifying 45x forward sales valuation.
PLTRvaluationenterprise software
The Motley FoolThe Motley Fool··Adam Spatacco

Palantir's 106x P/E Multiple Masks Hidden Value in AI-Powered National Security

Despite 106x forward P/E valuation, $PLTR may offer upside through government contracts and 139% net dollar retention as AI adoption accelerates.
PLTRvaluationenterprise software
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

$ODD Stock Crashes 49% After Revenue Collapse Tied to Undisclosed Ad Partner Issues

ODDITY Tech ($ODD) faces class action lawsuit over undisclosed algorithm changes from major ad partner that inflated customer acquisition costs, triggering 49% stock plunge.
ODDsecurities fraudclass action lawsuit
The Motley FoolThe Motley Fool··Keithen Drury

Can Palantir's AI Boom Deliver 100x Returns by 2035?

Palantir stock would need 35% annual earnings growth to deliver $1M on $10K investment by 2035, requiring normalization from current 232x P/E multiple.
PLTRstock valuationearnings growth
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Recursion Deepens Citeline Partnership to Supercharge AI Drug Discovery Platform

Recursion expands Citeline partnership to integrate real-world data into its AI drug discovery platform, achieving 30-60% trial enrollment improvements.
RXRXstrategic partnershipclinical development